Dextran prodrugs — structure and stability in relation to therapeutic activity

This publication has 196 references indexed in Scilit:

• In vitro drug release from macromolecule-drug conjugates of 3'-(7-carboxyheptanoyl)-5-fluoro-2'-deoxyuridine with decylenediamine-dextran T70 or poly-L-lysine.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
• Absorption characteristics of macromolecular prodrugs of mitomycin C following intramuscular administration.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• Preparation of dextran T70-methotrexate conjugate and dextran T70-mycophenolic acid conjugate, and in vitro effect of dextran T70-methotrexate on dihydrofolate reductase.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• Lymph node localization of non-specific antibody-coated liposomes
  Life Sciences, 1985
• Plasma disposition and in vivo and in vitro antiumor activities of mitomycin C-dextran conjugate in relation to the mode of action.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
• Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugate
  Biochemical and Biophysical Research Communications, 1983
• Requirement of macromolecular complex formation for selective lymphatic transfer of bleomycin from large intestine by bifunctional delivery system.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
• Dextran hypersensitivity
  Immunology Today, 1982
• Structure and properties of synthetic polymers of pharmacological and biomedical interest
  Die Makromolekulare Chemie, 1981
• Dextran-linked insulin: A soluble high molecular weight derivative with biological activity invivo and invitro
  Biochemical and Biophysical Research Communications, 1972